Cite

HARVARD Citation

    Siligato, R. et al. (2018). Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis. Expert opinion on investigational drugs. pp. 839-879. [Online]. 
  
Back to record